MedPath

Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)

Early Phase 1
Conditions
Refractory Overactive Bladder
Interventions
Device: PINS SNS
Registration Number
NCT02619721
Lead Sponsor
Beijing Pins Medical Co., Ltd
Brief Summary

Evaluate the long-term clinical effectiveness and safety of the PINS Sacral Neuromodulation to patients with refractory Overactive Bladder.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Age greater than 16 years OAB and/or OAB symptoms Refractory to standard medical therapy 100ml bladder capacity with normal upper urinary tract Good surgical candidate Able to complete study documentation and return for followup evaluation
Exclusion Criteria
  • Neurological conditions Stress urinary incontinence OAB symptoms caused by urinary tract infections

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sacral Neuromodulation is offPINS SNSSacral Neuromodulation is off after implantation
Sacral Neuromodulation is onPINS SNSSacral Neuromodulation is on as soon as implantation
Primary Outcome Measures
NameTimeMethod
Changes in voiding frequency from baseline to the voiding frequency evaluvation period 6 month6 month of stimulation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beijing Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath